Not applicableLooking for participantsNCT06304441
What this trial is testing
Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
Who this might be right for
Leptomeningeal Metastasis
Guangzhou Medical University 100